Arginine vasopressin (AVP), also known as argipressin or antidiuretic hormone (ADH), is a human hormone that is mainly released when the body is low on water; it causes the kidneys to conserve water by concentrating the urine and reducing urine volume. It has also various functions in the brain and blood vessels.

A very similar substance, lysine vasopressin (LVP) or lypressin, has the same function in pigs and is often used in human therapy.

These vasopressins are peptide hormones produced in the hypothalamus. Most of it is stored in the posterior part of the pituitary gland to be released into the blood stream; some of it is also released directly into the brain.

More on [ Vasopressin ]

CFDA: FDA Latest Computer Systems Warning Letters

WL Issued to Oncology Tech, LLP
FDA Fri, 27 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Oncology Tech, LLP on 27 Jun 2008 by Dallas District Office
WL Issued to Mostel, Edward, M.D.
FDA Fri, 16 May 2008 00:00:00 -0400
FDA Warning Letter Issued to Mostel, Edward, M.D. on 16 May 2008 by Center for Drug Evaluation and Research
WL Issued to Merck & Company, Inc.
FDA Mon, 28 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Merck & Company, Inc. on 28 Apr 2008 by Office of Enforcement
WL Issued to Blood Center of New Jersey
FDA Tue, 15 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Blood Center of New Jersey on 15 Apr 2008 by New Jersey District Office
WL Issued to Asfora, Wilson T. M.D.
FDA Mon, 07 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Asfora, Wilson T. M.D. on 07 Apr 2008 by Center for Devices and Radiological Health
WL Issued to Philips Medical Systems, Inc
FDA Tue, 01 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Philips Medical Systems, Inc on 01 Apr 2008 by Cincinnati District Office

CFDA: FDA Latest Drug GCP Warning Letters

WL Issued to Husain, Mustafa M, M.D.
FDA Wed, 23 Jul 2008 00:00:00 -0400
FDA Warning Letter Issued to Husain, Mustafa M, M.D. on 23 Jul 2008 by Center for Devices and Radiological Health
WL Issued to Bowers, James H. Jr., M.D.
FDA Tue, 08 Jul 2008 00:00:00 -0400
FDA Warning Letter Issued to Bowers, James H. Jr., M.D. on 08 Jul 2008 by Center for Devices and Radiological Health
WL Issued to Travanti Pharma, Inc.
FDA Mon, 30 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Travanti Pharma, Inc. on 30 Jun 2008 by Center for Drug Evaluation and Research
WL Issued to Ponugoti, Nagarjuna R., M.D.
FDA Fri, 06 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Ponugoti, Nagarjuna R., M.D. on 06 Jun 2008 by Center for Drug Evaluation and Research
WL Issued to Hamlin, Charles M.D.
FDA Mon, 02 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Hamlin, Charles M.D. on 02 Jun 2008 by Center for Devices and Radiological Health
WL Issued to Synapse Biomedical Inc.
FDA Sun, 01 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Synapse Biomedical Inc. on 01 Jun 2008 by Center for Devices and Radiological Health

Subscribe to Drugs_and_Medications RSS feed